{{Rsnum
|rsid=10740051
|Gene=NCOA4
|Chromosome=10
|position=51570152
|Orientation=plus
|GMAF=0.2594
|Gene_s=NCOA4,TIMM23B
|Assembly=GRCh37.p2
|GenomeBuild=37.2
|dbSNPBuild=134
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.9 | 35.4 | 48.7
| HCB | 21.9 | 42.3 | 35.8
| JPT | 16.1 | 54.5 | 29.5
| YRI | 0.0 | 10.9 | 89.1
| ASW | 0.0 | 15.8 | 84.2
| CHB | 21.9 | 42.3 | 35.8
| CHD | 19.3 | 45.9 | 34.9
| GIH | 29.7 | 51.5 | 18.8
| LWK | 0.9 | 18.2 | 80.9
| MEX | 1.8 | 22.8 | 75.4
| MKK | 1.9 | 28.8 | 69.2
| TSI | 8.8 | 45.1 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=20717903
|Title=Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: The flint men's health study
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}